The U.S. Medicare program is testing an AI-assisted system called WISeR (Wasteful and Inappropriate Service Reduction Model) to help review and preapprove certain medical procedures. The initiative is designed to reduce fraud, unnecessary treatments, and healthcare costs by using artificial intelligence to evaluate requests before services are provided. The pilot program is currently operating in six states and covers a limited set of procedures considered vulnerable to waste or misuse.
However, the rollout has generated significant criticism from patients, doctors, and healthcare providers. According to reports, some users have experienced administrative errors, confusing decisions, lengthy wait times, and delays in receiving care. Healthcare professionals involved in the pilot have described the implementation as problematic, arguing that patients in traditional Medicare are now encountering bureaucratic hurdles similar to those long associated with private insurance prior-authorization systems.
Federal officials and technology vendors maintain that AI is being used only as a support tool and that human clinicians make the final coverage decisions. They also report that many requests meeting established criteria are approved quickly. Nevertheless, some physicians believe AI plays a larger role than advertised and have raised concerns about inaccurate recommendations, incomplete reviews, and the possibility of AI-generated mistakes influencing patient care decisions.
The controversy highlights a broader debate over the use of artificial intelligence in healthcare administration. Supporters argue that AI can speed up approvals, reduce costs, and improve efficiency, while critics worry that automated systems may create new barriers to care and reduce accountability. As the WISeR pilot continues, policymakers and healthcare experts will be closely watching whether the technology ultimately improves patient outcomes or adds another layer of complexity to the healthcare system.
